vTv Therapeutics Inc.VTVTNASDAQ
Loading
Year-over-year gross profit growth rate
Latest
0.00%
↑ 100% vs avg
Percentile
P36
Within normal range
Average
-2111.51%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 100.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | -100.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | -100.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 100.00% |
| Q2 2022 | -93.82% |
| Q1 2022 | 75.86% |
| Q4 2021 | -859.39% |
| Q3 2021 | 125.45% |
| Q2 2021 | -14.74% |
| Q1 2021 | -154.75% |
| Q4 2020 | 319.48% |
| Q3 2020 | 73.77% |
| Q2 2020 | -84012.50% |
| Q1 2020 | 100.18% |
| Q4 2019 | -20.36% |
| Q3 2019 | -52.29% |
| Q2 2019 | -26.25% |
| Q1 2019 | -210.39% |
| Q4 2018 | 154.36% |
| Q3 2018 | 111.06% |
| Q2 2018 | 11.02% |
| Q1 2018 | 30.06% |
| Q4 2017 | -9.59% |
| Q3 2017 | 6.62% |
| Q2 2017 | 12.08% |
| Q1 2017 | 1.18% |
| Q4 2016 | 0.59% |
| Q3 2016 | 7.02% |
| Q2 2016 | -9.20% |
| Q1 2016 | -25.68% |